Immunoclin Corp: 10-Q/A filed 2011-11-02

Name: Immunoclin Corp: 10-Q/A filed 2011-11-02
Creator: Immunoclin Corp

What Immunoclin Corp reported in its quarterly report amendment filed 2011-11-02 (fiscal Q2 2011): 17 published measures, 39 facts as tagged in accession 0001078782-11-003119.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form: 10-Q/A (quarterly report amendment)
Filed: 2011-11-02
Fiscal period: fiscal Q2 2011
Accession: 0001078782-11-003119 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Immunoclin Corp filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-08-31	4,121	USD
At 2011-02-28	9,000	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2011-08-31	49,208	USD
At 2011-02-28	15,000	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2011-08-31	-45,087	USD
At 2011-02-28	-6,000	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-08-31	4,121	USD
At 2011-02-28	9,000	USD
At 2011-01-31	0	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-03-01 to 2011-08-31	-39,087	USD	184
2011-02-01 to 2011-08-31	-45,087	USD	212

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-03-01 to 2011-08-31	-26,705	USD	184
2011-02-01 to 2011-08-31	-27,705	USD	212

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Unit	Days
2011-06-01 to 2011-08-31	USD	92
2011-03-01 to 2011-08-31	USD	184
2011-02-01 to 2011-08-31	USD	212

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-03-01 to 2011-08-31	21,826	USD	184
2011-02-01 to 2011-08-31	31,826	USD	212

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2011-08-31	-45,087	USD
At 2011-02-28	-6,000	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2011-08-31	17,382	USD
At 2011-02-28	5,000	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2011-06-01 to 2011-08-31	24,113	USD	92
2011-03-01 to 2011-08-31	39,087	USD	184
2011-02-01 to 2011-08-31	45,087	USD	212

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-08-31	5,000,000	shares
At 2011-02-28	5,000,000	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2011-08-31	-5,000	USD
At 2011-02-28	-5,000	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2011-06-01 to 2011-08-31	-24,113	USD	92
2011-03-01 to 2011-08-31	-39,087	USD	184
2011-02-01 to 2011-08-31	-45,087	USD	212

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2011-06-01 to 2011-08-31	1,321	USD	92
2011-03-01 to 2011-08-31	2,503	USD	184
2011-02-01 to 2011-08-31	3,503	USD	212

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2011-03-01 to 2011-08-31	0	USD	184
2011-02-01 to 2011-08-31	0	USD	212

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2011-03-01 to 2011-08-31	12,382	USD	184
2011-02-01 to 2011-08-31	17,382	USD	212

Inspect the source

Entity: Immunoclin Corp / CIK 0001520047
Captured: 2026-09-23 02:58 UTC
SEC response SHA-256: cdfbf3ddd493bed046dd28be8c53e20201b60478d7022019645c6ed835ac7b05

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001520047.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))